{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:07:58Z","timestamp":1781780878406,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12957-016-1048-5","type":"journal-article","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T02:01:53Z","timestamp":1480039313000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer"],"prefix":"10.1186","volume":"14","author":[{"given":"Masaya","family":"Tamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munehisa","family":"Takata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,25]]},"reference":[{"key":"1048_CR1","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1200\/JCO.2000.18.16.2981","volume":"18","author":"F Andre","year":"2000","unstructured":"Andre F, Grunenwald D, Pignon JP, Dujon A, Pujol JL, et al. Survival of patients with resected N2 non-small cell lung cancer: evidence for a subclassification and implications. J Clin Oncol. 2000;18:2981\u20139.","journal-title":"J Clin Oncol"},{"key":"1048_CR2","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jtcvs.2003.09.012","volume":"127","author":"M Inoue","year":"2004","unstructured":"Inoue M, Sawabata N, Takeda S, Ohta M, Ohno Y, et al. Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe. J Thorac Cardiovasc Surgery. 2004;127:1100\u20136.","journal-title":"J Thorac Cardiovasc Surgery"},{"key":"1048_CR3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-5223(99)70153-4","volume":"118","author":"K Suzuki","year":"1999","unstructured":"Suzuki K, Nagai K, Yoshida J, Nishimura M, Takahashi K, et al. The prognosis of surgically resected N2 non-small cell lung cancer: the importance of clinical N status. J Thorac Cardiovasc Surg. 1999;118:145\u201353.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"1048_CR4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/thx.2010.148601","volume":"66","author":"JP Wisnivesky","year":"2011","unstructured":"Wisnivesky JP, Arciniega J, Mhango G, Mandeli J, Halm EA. Lymph node ratio as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancer. Thorax. 2011;66(4):287\u201393.","journal-title":"Thorax"},{"issue":"2","key":"1048_CR5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00268-011-1360-8","volume":"36","author":"CL Wang","year":"2012","unstructured":"Wang CL, Li Y, Yue DS, Zhang LM, Zhang ZF, et al. Value of the metastatic lymph node ratio for predicting the prognosis of non-small cell lung cancer patients. World J Surg. 2012;36(2):455\u201362.","journal-title":"World J Surg"},{"key":"1048_CR6","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1378\/chest.100.2.422","volume":"100","author":"Y Watanabe","year":"1991","unstructured":"Watanabe Y, Hayashi Y, Shimizu J, Oda M, Iwa T. Mediastinal nodal involvement and prognosis of non-small cell lung cancer. Chest. 1991;100:422\u20138.","journal-title":"Chest"},{"key":"1048_CR7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1067\/mtc.2001.116473","volume":"122","author":"Y Ichinose","year":"2001","unstructured":"Ichinose Y, Kato H, Koike T, Tsuchiya R, Fujisawa T, et al. Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station. J Thorac Cardiovasc Surg. 2001;122:803\u20138.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1048_CR8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.athoracsur.2004.06.081","volume":"79","author":"M Riquet","year":"2005","unstructured":"Riquet M, Assouad J, Bagan P, Foucault C, Le Pimpec BF, et al. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis. Ann Thorac Surg. 2005;79:225\u201333.","journal-title":"Ann Thorac Surg"},{"key":"1048_CR9","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1378\/chest.111.6.1718","volume":"111","author":"CF Mountain","year":"1997","unstructured":"Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest. 1997;111:1718\u201323.","journal-title":"Chest"},{"key":"1048_CR10","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0022-5223(19)39559-5","volume":"76","author":"T Naruke","year":"1978","unstructured":"Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg. 1978;76:832\u20139.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1048_CR11","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.athoracsur.2008.07.076","volume":"86","author":"P Misthos","year":"2008","unstructured":"Misthos P, Sepsas E, Kokotsakis J, Skottis I, Lioulias A. The significance of one-station N2 disease in the prognosis of patients with non-small cell lung cancer. Ann Thorac Surg. 2008;86:1626\u201330.","journal-title":"Ann Thorac Surg"},{"key":"1048_CR12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/jso.10219","volume":"82","author":"KL Prenzel","year":"2003","unstructured":"Prenzel KL, Monig SP, Sinning JM, Baldus SE, Gutshow CA, et al. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer. J Surg Oncol. 2003;82:256\u201360.","journal-title":"J Surg Oncol"},{"issue":"5","key":"1048_CR13","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ejso.2006.02.004","volume":"32","author":"L Benoit","year":"2006","unstructured":"Benoit L, Anusca A, Ortega-Deballon P, Cheynel N, Bernard A, et al. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma. Eur J Surg Oncol. 2006;32(5):583\u20137.","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"1048_CR14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.lungcan.2009.02.024","volume":"66","author":"E Bria","year":"2009","unstructured":"Bria E, Milella M, Sperduti I, Alessandrini G, Visca P, et al. A novel clinical prognostic score incorporating the number of resected lymph nodes to predict recurrence and survival in non-small cell lung cancer. Lung Cancer. 2009;66(3):365\u201371.","journal-title":"Lung Cancer"},{"key":"1048_CR15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.athoracsur.2005.06.077","volume":"81","author":"Y Sakao","year":"2006","unstructured":"Sakao Y, Miyamoto H, Yamazaki A, Oh T, Fukai R, et al. Prognostic significance of metastasis to the highest mediastinal lymph node in non-small cell lung cancer. Ann Thorac Surg. 2006;81:292\u20137.","journal-title":"Ann Thorac Surg"},{"key":"1048_CR16","first-page":"1","volume":"14","author":"M Saito","year":"2008","unstructured":"Saito M, Kato H. Prognostic factor in patients with pathological and N2 non-small cell lung cancer. Ann Thorac Cardiovasc Surg. 2008;14:1\u20132.","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"1048_CR17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1378\/chest.123.2.463","volume":"123","author":"KL Prenzel","year":"2003","unstructured":"Prenzel KL, Monig SP, Sinning JM, Baldus SE, Brochhagen HG, et al. Lymph node size and metastatic infiltration in non-small cell lung cancer. Chest. 2003;123:463\u20137.","journal-title":"Chest"},{"key":"1048_CR18","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/jnci\/djm232","volume":"99","author":"YC Ung","year":"2007","unstructured":"Ung YC, Mazlak DE, Vanderveen JA, Smith CA, Gulenchyn K, et al. Lung Cancer Disease Site Group of Cancer Care Ontarios Program in Evidence-Based Care. 18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review. J Natl Cancer Inst. 2007;99:1753\u201367.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"1048_CR19","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s12149-011-0529-4","volume":"25","author":"K Kubota","year":"2011","unstructured":"Kubota K, Murakami K, Inoue T, Itoh H, Saga T, et al. Additional value of FDG-PET to contrast enhanced computed tomography (CT) for the diagnosis of mediastinal lymph node metastasis in non-small cell lung cancer: a Japanese multicenter clinical study. Ann Nucl Med. 2011;25(10):777\u201386.","journal-title":"Ann Nucl Med"},{"issue":"6","key":"1048_CR20","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1072-7515(98)00229-4","volume":"187","author":"Y Kodera","year":"1998","unstructured":"Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, et al. The number of metastatic lymph nodes: a promising prognostic determinant for gastric carcinoma in the latest edition of the TNM classification. J Am Coll Surg. 1998;187(6):597\u2013603.","journal-title":"J Am Coll Surg"},{"issue":"4","key":"1048_CR21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/(SICI)1097-0142(19990815)86:4<553::AID-CNCR2>3.0.CO;2-D","volume":"86","author":"T Ichikura","year":"1999","unstructured":"Ichikura T, Tomimatsu S, Uefuji K, Kimura M, Uchida T, et al. Evaluation of the new American joint committee on cancer\/international union against cancer classification of lymph node metastasis from gastric carcinoma in comparison with the Japanese classification. Cancer. 1999;86(4):553\u20138.","journal-title":"Cancer"},{"issue":"1","key":"1048_CR22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1470-2045(03)00961-6","volume":"4","author":"JR Benson","year":"2003","unstructured":"Benson JR, Weaver DL, Mittra I, Hayashi M. The TNM staging system and breast cancer. Lancet Oncol. 2003;4(1):56\u201360.","journal-title":"Lancet Oncol"},{"key":"1048_CR23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00292-010-1307-0","volume":"31","author":"HP Sinn","year":"2010","unstructured":"Sinn HP, Helmchen B, Wittekind CH. TNM classification of breast cancer: changes and comments on the 7th edition. Pathologe. 2010;31:361\u20136.","journal-title":"Pathologe"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-016-1048-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T13:59:22Z","timestamp":1601215162000},"score":1,"resource":{"primary":{"URL":"http:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-016-1048-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,25]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1048"],"URL":"https:\/\/doi.org\/10.1186\/s12957-016-1048-5","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,25]]},"article-number":"295"}}